Researchers are investigating whether mifepristone—a medication already approved for treating uterine fibroids and endometriosis—could also help prevent certain cancers in women. The potential new applications come as political and regulatory hurdles continue to shape access to these drugs, raising questions about how such barriers might impact future medical advancements. A deeper look at the challenges and opportunities in this evolving area of women’s health research is explored in this report.
For years, mifepristone and similar drugs have been used to treat uterine fibroids and endometriosis. Now researchers are exploring whether these drugs could have other uses in women's health, including preventing some cancers. But the politics and restrictions surrounding these drugs could affect the research. Special correspondent Sarah Varney reports for our series, Beyond Abortion.
